MARCHESINI REGGIANI, GIULIO
MARCHESINI REGGIANI, GIULIO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Giulio Marchesini; Marchesini Giulio; G Marchesini Reggiani; Reggiani GM; MARCHESINI REGGIANI G.; Marchesini G.; G MARCHESINI; G. REGGIANI MARCHESINI; Giulio Marchesini Reggiani
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity
2024 Brodosi, Lucia; Stecchi, Michele; Musio, Alessandra; Bazzocchi, Matilde; Risi, Eleonora; Marchignoli, Francesca; Marchesini, Giulio; Petroni, Maria Letizia
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus
2024 Nugnes M.; Baldassarre M.; Ribichini D.; Tedesco D.; Capelli I.; Vetrano D.; Marchignoli F.; Brodosi L.; Pompili E.; Petroni M.L.; La Manna G.; Marchesini G.; Naldi M.; Bartolini M.
Editorial: Does knowledge about liver disease enhance adherence to lifestyle recommendations? Authors' reply
2024 Petroni, Maria Letizia; Colosimo, Santo; Marchesini, Giulio
Metformin and the Liver: Unlocking the Full Therapeutic Potential
2024 Perazza, Federica; Leoni, Laura; Colosimo, Santo; Musio, Alessandra; Bocedi, Giulia; D'Avino, Michela; Agnelli, Giulio; Nicastri, Alba; Rossetti, Chiara; Sacilotto, Federica; Marchesini, Giulio; Petroni, Maria Letizia; Ravaioli, Federico
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs
2023 Petroni M.L.; Brodosi L.; Armandi A.; Marchignoli F.; Bugianesi E.; Marchesini G.
Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting
2023 Petroni, Maria Letizia; Colosimo, Santo; Brodosi, Lucia; Armandi, Angelo; Bertini, Flavio; Montesi, Danilo; Bugianesi, Elisabetta; Marchesini, Giulio
Looking ahead to potential incretin combination therapies for nonalcoholic steatohepatitis in patients with diabetes
2023 Brodosi, Lucia; Petroni, Maria Letizia; Marchesini, Giulio
NAFLD, the hepatic manifestation of the metabolic syndrome
2023 Tirthankar Chaudhury, Lucia Brodosi, Giulio Marchesini, Sandip Kumar Mitra, Maria Letizia Petroni
The treatment of diabetes in advanced liver disease: change of a paradigm
2023 Petroni, Maria Letizia; Brodosi, Lucia; Marchesini, Giulio
Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease
2022 Brodosi L.; Marchignoli F.; Marchesini G.; Petroni M.L.
From liver fat to full-blown metabolic disorder: the kidney as target organ
2022 Petroni, Maria L.; Marchesini, Giulio
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients
2022 Brodosi, Lucia; Petta, Salvatore; Petroni, Maria L; Marchesini, Giulio; Morelli, Maria C
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
2022 Marchesini G.; Bugianesi E.; Burra P.; Marra F.; Miele L.; Alisi A.; Vajro P.; Masarone M.; Petta S.; Persico M.; Svegliati-Baroni G.; Valenti L.; Federici M.; Purrello F.; Sasso F.C.; Targher G.; Busetto L.; Petroni M.L.; Santini F.; Camma C.; Colli A.
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
2022 Marchesini G.; Bugianesi E.; Burra P.; Marra F.; Miele L.; Alisi A.; Vajro P.; Masarone M.; Petta S.; Persico M.; Svegliati-Baroni G.; Valenti L.; Federici M.; Purrello F.; Sasso F.C.; Targher G.; Busetto L.; Petroni M.L.; Santini F.; Camma C.; Colli A.
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy
2022 Ravaioli, Federico; Petroni, Maria Letizia; Marchignoli, Francesca; Leoni, Laura; Bocedi, Giulia; Sacilotto, Federica; Osti, Valentino; Mita, Dorina; Barbanti, Francesca; Brodosi, Lucia; Reggiani, Giulio Marchesini; Pironi, Loris
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
2022 Karlsen T.H.; Sheron N.; Zelber-Sagi S.; Carrieri P.; Dusheiko G.; Bugianesi E.; Pryke R.; Hutchinson S.J.; Sangro B.; Martin N.K.; Cecchini M.; Dirac M.A.; Belloni A.; Serra-Burriel M.; Ponsioen C.Y.; Sheena B.; Lerouge A.; Devaux M.; Scott N.; Hellard M.; Verkade H.J.; Sturm E.; Marchesini G.; Yki-Jarvinen H.; Byrne C.D.; Targher G.; Tur-Sinai A.; Barrett D.; Ninburg M.; Reic T.; Taylor A.; Rhodes T.; Treloar C.; Petersen C.; Schramm C.; Flisiak R.; Simonova M.Y.; Pares A.; Johnson P.; Cucchetti A.; Graupera I.; Lionis C.; Pose E.; Fabrellas N.; Ma A.T.; Mendive J.M.; Mazzaferro V.; Rutter H.; Cortez-Pinto H.; Kelly D.; Burton R.; Lazarus J.V.; Gines P.; Buti M.; Newsome P.N.; Burra P.; Manns M.P.
The Role of Psychological Well-Being in Weight Loss: New Insights from a Comprehensive Lifestyle Intervention
2022 Zhu B.; Gostoli S.; Benasi G.; Patierno C.; Petroni M.L.; Nuccitelli C.; Marchesini G.; Fava G.A.; Rafanelli C.
Analysis of clinical profiles, deformities, and plantar pressure patterns in diabetic foot syndrome
2021 Giacomozzi C.; Lullini G.; Leardini A.; Caravaggi P.; Ortolani M.; Marchesini G.; Baccolini L.; Berti L.
Eating habits in patients affected by metabolic syndrome and liver disease (hepatitis, cirrhosis and liver transplant)
2021 Brodosi L, Mita D, Simonetti G, Vitale G, Gentile A, Genovese M, Marchesini G, Morelli MC, Pironi L.
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis
2021 Colosimo, Santo; Ravaioli, Federico; Petroni, Maria L; Brodosi, Lucia; Marchignoli, Francesca; Barbanti, Francesca A; Sasdelli, Anna S; Marchesini, Giulio; Pironi, Loris
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity | Brodosi, Lucia; Stecchi, Michele; Musio, Alessandra; Bazzocchi, Matilde; Risi, Eleonora; Marchign...oli, Francesca; Marchesini, Giulio; Petroni, Maria Letizia | 2024-01-01 | ACTA DIABETOLOGICA | - | 1.01 Articolo in rivista | - |
| Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus | Nugnes M.; Baldassarre M.; Ribichini D.; Tedesco D.; Capelli I.; Vetrano D.; Marchignoli F.; Brod...osi L.; Pompili E.; Petroni M.L.; La Manna G.; Marchesini G.; Naldi M.; Bartolini M. | 2024-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-25-03168.pdf; Supplementary materials.docx |
| Editorial: Does knowledge about liver disease enhance adherence to lifestyle recommendations? Authors' reply | Petroni, Maria Letizia; Colosimo, Santo; Marchesini, Giulio | 2024-01-01 | ALIMENTARY PHARMACOLOGY AND THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Metformin and the Liver: Unlocking the Full Therapeutic Potential | Perazza, Federica; Leoni, Laura; Colosimo, Santo; Musio, Alessandra; Bocedi, Giulia; D'Avino, Mic...hela; Agnelli, Giulio; Nicastri, Alba; Rossetti, Chiara; Sacilotto, Federica; Marchesini, Giulio; Petroni, Maria Letizia; Ravaioli, Federico | 2024-01-01 | METABOLITES | - | 1.01 Articolo in rivista | - |
| Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs | Petroni M.L.; Brodosi L.; Armandi A.; Marchignoli F.; Bugianesi E.; Marchesini G. | 2023-01-01 | NUTRIENTS | - | 1.01 Articolo in rivista | 32_Brodosi et al_ WEBvsGruppi.pdf |
| Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting | Petroni, Maria Letizia; Colosimo, Santo; Brodosi, Lucia; Armandi, Angelo; Bertini, Flavio; Montes...i, Danilo; Bugianesi, Elisabetta; Marchesini, Giulio | 2023-01-01 | ALIMENTARY PHARMACOLOGY AND THERAPEUTICS | - | 1.01 Articolo in rivista | Aliment Pharmacol Ther - 2023 - Petroni - Long‐term follow‐up of web‐based and group‐based behavioural intervention in.pdf |
| Looking ahead to potential incretin combination therapies for nonalcoholic steatohepatitis in patients with diabetes | Brodosi, Lucia; Petroni, Maria Letizia; Marchesini, Giulio | 2023-01-01 | EXPERT OPINION ON PHARMACOTHERAPY | - | 1.01 Articolo in rivista | - |
| NAFLD, the hepatic manifestation of the metabolic syndrome | Tirthankar Chaudhury, Lucia Brodosi, Giulio Marchesini, Sandip Kumar Mitra, Maria Letizia Petroni | 2023-01-01 | - | Academic Press | 2.01 Capitolo / saggio in libro | - |
| The treatment of diabetes in advanced liver disease: change of a paradigm | Petroni, Maria Letizia; Brodosi, Lucia; Marchesini, Giulio | 2023-01-01 | ANNALS OF HEPATOLOGY | - | 1.01 Articolo in rivista | 1-s2.0-S1665268122001144-main.pdf |
| Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease | Brodosi L.; Marchignoli F.; Marchesini G.; Petroni M.L. | 2022-01-01 | EXPERT OPINION ON PHARMACOTHERAPY | - | 1.01 Articolo in rivista | - |
| From liver fat to full-blown metabolic disorder: the kidney as target organ | Petroni, Maria L.; Marchesini, Giulio | 2022-01-01 | METABOLISM AND TARGET ORGAN DAMAGE | - | 1.01 Articolo in rivista | - |
| Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients | Brodosi, Lucia; Petta, Salvatore; Petroni, Maria L; Marchesini, Giulio; Morelli, Maria C | 2022-01-01 | TRANSPLANTATION | - | 1.01 Articolo in rivista | Management_of_Diabetes_in_Candidates_for_Liver.15.pdf |
| Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) | Marchesini G.; Bugianesi E.; Burra P.; Marra F.; Miele L.; Alisi A.; Vajro P.; Masarone M.; Petta... S.; Persico M.; Svegliati-Baroni G.; Valenti L.; Federici M.; Purrello F.; Sasso F.C.; Targher G.; Busetto L.; Petroni M.L.; Santini F.; Camma C.; Colli A. | 2022-01-01 | NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | - | 1.01 Articolo in rivista | PIIS0939475321002210.pdf; ScienceDirect_files_24Nov2023_12-26-57.337.zip |
| Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) | Marchesini G.; Bugianesi E.; Burra P.; Marra F.; Miele L.; Alisi A.; Vajro P.; Masarone M.; Petta... S.; Persico M.; Svegliati-Baroni G.; Valenti L.; Federici M.; Purrello F.; Sasso F.C.; Targher G.; Busetto L.; Petroni M.L.; Santini F.; Camma C.; Colli A. | 2022-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | LG NAFLD.pdf; ScienceDirect_files_13Apr2022_13-35-46.377.zip |
| Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy | Ravaioli, Federico; Petroni, Maria Letizia; Marchignoli, Francesca; Leoni, Laura; Bocedi, Giulia;... Sacilotto, Federica; Osti, Valentino; Mita, Dorina; Barbanti, Francesca; Brodosi, Lucia; Reggiani, Giulio Marchesini; Pironi, Loris | 2022-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality | Karlsen T.H.; Sheron N.; Zelber-Sagi S.; Carrieri P.; Dusheiko G.; Bugianesi E.; Pryke R.; Hutchi...nson S.J.; Sangro B.; Martin N.K.; Cecchini M.; Dirac M.A.; Belloni A.; Serra-Burriel M.; Ponsioen C.Y.; Sheena B.; Lerouge A.; Devaux M.; Scott N.; Hellard M.; Verkade H.J.; Sturm E.; Marchesini G.; Yki-Jarvinen H.; Byrne C.D.; Targher G.; Tur-Sinai A.; Barrett D.; Ninburg M.; Reic T.; Taylor A.; Rhodes T.; Treloar C.; Petersen C.; Schramm C.; Flisiak R.; Simonova M.Y.; Pares A.; Johnson P.; Cucchetti A.; Graupera I.; Lionis C.; Pose E.; Fabrellas N.; Ma A.T.; Mendive J.M.; Mazzaferro V.; Rutter H.; Cortez-Pinto H.; Kelly D.; Burton R.; Lazarus J.V.; Gines P.; Buti M.; Newsome P.N.; Burra P.; Manns M.P. | 2022-01-01 | THE LANCET | - | 1.01 Articolo in rivista | EASL_LancetLiver_Commission_AM.pdf |
| The Role of Psychological Well-Being in Weight Loss: New Insights from a Comprehensive Lifestyle Intervention | Zhu B.; Gostoli S.; Benasi G.; Patierno C.; Petroni M.L.; Nuccitelli C.; Marchesini G.; Fava G.A....; Rafanelli C. | 2022-01-01 | INTERNATIONAL JOURNAL OF CLINICAL AND HEALTH PSYCHOLOGY | - | 1.01 Articolo in rivista | main.pdf |
| Analysis of clinical profiles, deformities, and plantar pressure patterns in diabetic foot syndrome | Giacomozzi C.; Lullini G.; Leardini A.; Caravaggi P.; Ortolani M.; Marchesini G.; Baccolini L.; B...erti L. | 2021-01-01 | APPLIED SCIENCES | - | 1.01 Articolo in rivista | applsci-11-11464.pdf |
| Eating habits in patients affected by metabolic syndrome and liver disease (hepatitis, cirrhosis and liver transplant) | Brodosi L, Mita D, Simonetti G, Vitale G, Gentile A, Genovese M, Marchesini G, Morelli MC, Pironi L. | 2021-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.01 Contributo in Atti di convegno | - |
| Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis | Colosimo, Santo; Ravaioli, Federico; Petroni, Maria L; Brodosi, Lucia; Marchignoli, Francesca; Ba...rbanti, Francesca A; Sasdelli, Anna S; Marchesini, Giulio; Pironi, Loris | 2021-01-01 | LIVER INTERNATIONAL | - | 1.01 Articolo in rivista | liv.14799-1-1.pdf; liv14799-sup-0001-tables1-s3.docx |